atomoxetine hydrochloride has been researched along with Hyperactivity, Motor in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botanas, CJ; Cheong, JH; Custodio, RJ; de la Peña, JB; Dela Peña, I; Dela Peña, IJI; Kim, BN; Kim, HJ; Ryoo, ZY; Ryu, JH | 1 |
| Beaulieu, JM; Del'Guidice, T; Escoffier, G; Etiévant, A; Lemasson, M; Magno, LA; Manta, S; Roman, FS | 1 |
| Heal, DJ; Pillidge, K; Porter, AJ; Stanford, SC; Vasili, T | 1 |
| Ago, Y; Baba, A; Hashimoto, H; Hashimoto, R; Hayata-Takano, A; Hazama, K; Kasai, A; Katayama, T; Köves, K; Matsuda, T; Matsuzaki, S; Nagayasu, K; Nakazawa, T; Onaka, Y; Reglődi, D; Shibasaki, Y; Shintani, N; Tamas, A; Tanida, M; Taniike, M; Waschek, JA; Yamada, K | 1 |
| Abe, M; Baba, A; Hashimoto, H; Köves, K; Kubo, M; Kuroda, M; Shibasaki, Y; Shintani, N; Tsuchida, R | 1 |
| Arai, Y; Hiraga, H; Murai, S; Nakagawasai, O; Niijima, F; Saito, H; Tadano, T; Tan-No, K; Watanabe, H | 1 |
| Granger, RE; Hazell, PL; Kohn, MR; van Wyk, GW; Walton, RJ | 1 |
| Baldessarini, RJ; Moran-Gates, T; Tarazi, FI; Zhang, K | 1 |
1 review(s) available for atomoxetine hydrochloride and Hyperactivity, Motor
| Article | Year |
|---|---|
How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Hyperkinesis; Methylphenidate; Propylamines; Treatment Outcome | 2012 |
7 other study(ies) available for atomoxetine hydrochloride and Hyperactivity, Motor
| Article | Year |
|---|---|
The Atxn7-overexpressing mice showed hyperactivity and impulsivity which were ameliorated by atomoxetine treatment: A possible animal model of the hyperactive-impulsive phenotype of ADHD.
Topics: Adrenergic Uptake Inhibitors; Animals; Ataxin-7; Atomoxetine Hydrochloride; Delay Discounting; Green Fluorescent Proteins; Hyperkinesis; Impulsive Behavior; Locomotion; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptors, Dopamine D1; Recognition, Psychology; RNA, Messenger; Rotarod Performance Test; Statistics, Nonparametric | 2019 |
Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
Topics: Amphetamine; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cognition; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hyperkinesis; Maze Learning; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Norepinephrine; Propylamines; Psychomotor Performance; Serotonin; Serotonin Agents; Smell | 2014 |
Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Hyperkinesis; Impulsive Behavior; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Propylamines; Receptors, Neurokinin-1 | 2014 |
Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Biogenic Monoamines; Cognition Disorders; Dose-Response Relationship, Drug; Exploratory Behavior; Hyperkinesis; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Pituitary Adenylate Cyclase-Activating Polypeptide; Prepulse Inhibition; Recognition, Psychology | 2015 |
An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Dioxanes; Dioxoles; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Piperazines; Propylamines; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Effects of atomoxetine on levels of monoamines and related substances in discrete brain regions in mice intermittently deprived of rapid eye movement sleep.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Dopamine; Frontal Lobe; Hyperkinesis; Male; Mice; Mice, Inbred Strains; Movement; Norepinephrine; Propylamines; Sleep Deprivation; Sleep, REM | 2010 |
Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Animals, Newborn; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Hyperkinesis; Male; Oxidopamine; Propylamines; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |